QTRXQuanterix Corp
$3.13
$0.17
(5.15%)
Closed $3.13
$0.00
(0.00%)
After Hours
EarningsAug 6
Mkt Cap$155.45M
Vol600,038.00
Fundamentals
Mkt Cap
$155.45M
Volume
-
52W High
$8.77
52W Low
$2.40
PE Ratio
-1.39
Avg. Volume
1.54M
EPS (Annual)
-$2.51
Rev/Employee
$308,660.00
Earnings
Aug 06
Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Geoff Albrecht as Senior Vice President and General Manager of Diagnostics. This strategic hire underscores Quanterixs...
Business Wire
Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that senior management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference being held in Miami, FL from June...
Business Wire
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on May 15, 2026, an inducement grant (the Inducement Grant) was made to Anthony Catalano in connection with...
Business Wire
Quanterix Announces Planned Transition of Chief Financial Officer
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that Vandana Sriram, its Chief Financial Officer (CFO) will depart the Company. A search for her successor is ongoing, and Ms. Sriram will...
Business Wire
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates
Quanterix (QTRX) delivered earnings and revenue surprises of -25.81% and -0.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Quanterix Releases Financial Results for the First Quarter of 2026
Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the first quarter...
Business Wire
Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimers Biomarker Testing into Clinical Workflows
Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), today announced a collaboration with Tempus AI Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance...
Business Wire
Quanterix (QTRX) Expected to Announce Quarterly Earnings on Wednesday
Quanterix (NASDAQ:QTRX) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at...
MarketBeat
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on...
Business Wire
Wall Street Zen Downgrades Quanterix (NASDAQ:QTRX) to Sell
Wall Street Zen cut shares of Quanterix from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat
<
1
2
...
>
Advertisement|Remove ads.
Latest QTRX News
ViewQuanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics
Business Wire
Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Business Wire
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire
Advertisement|Remove ads.